Philip Karl Herman's most recent trade in Y-Mabs Therapeutics Inc was a trade of 20,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Dec. 15, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Y-Mabs Therapeutics Inc | Philip Karl Herman | SVP & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 20,000 | 20,000 | - | - | Employee Stock Option (right to buy) |